Literature DB >> 28994254

HMG CoA reductase inhibitor associated myositis and autoimmune hepatitis.

Dharmenaan Palamuthusingam1, Murty Mantha2, Shyam Dheda2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28994254     DOI： 10.1111/imj.13561

Source DB:  PubMed          Journal:  Intern Med J        ISSN： 1444-0903            Impact factor:   2.048


× No keyword cloud information.
  3 in total

Review 1.  Statin-induced myalgia and myositis: an update on pathogenesis and clinical recommendations.

Authors:  Albert Selva-O'Callaghan; Marcelo Alvarado-Cardenas; Iago Pinal-Fernández; Ernesto Trallero-Araguás; José Cesar Milisenda; María Ángeles Martínez; Ana Marín; Moisés Labrador-Horrillo; Cándido Juárez; Josep María Grau-Junyent
Journal:  Expert Rev Clin Immunol       Date:  2018-02-23       Impact factor: 4.473

2.  Statin-induced necrotising autoimmune myopathy and autoimmune hepatitis presenting with dysphagia.

Authors:  Osama Qasim Agha; Sukhdeep Kaur; Nirmal Vijayavel
Journal:  BMJ Case Rep       Date:  2020-02-05

3.  Anti-HMGCR Specificity of HALIP: A Confirmatory Study.

Authors:  Andrés Baucells; Maria Angeles Martínez; Marcelo Alvarado-Cardenas; Anaís Mariscal; Laura Martinez-Martinez; Cándido Juárez; Albert Selva-O'Callaghan
Journal:  J Immunol Res       Date:  2020-07-16       Impact factor: 4.818
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.